Wing‐Kai Chan
- Cancer Research top 2%
- Oncology top 2%
- Cancer Treatment and Pharmacology 14
- Colorectal Cancer Treatments and Studies 8
- Lung Cancer Research Studies 7
- Hepatology top 2%
- Hepatocellular Carcinoma Treatment and Prognosis 9
-
- Lung Cancer Treatments and Mutations 5
- Otorhinolaryngology top 5%
-
- Pharmacogenetics and Drug Metabolism 6
-
- Cancer therapeutics and mechanisms 6
-
- Neuroendocrine Tumor Research Advances 5
- Co-authors
- Pan‐Chyr YangAng YuanSung‐Liang YuYee ChaoJeremy J.W. ChenJin‐Yuan ShihHsuan‐Yu ChenGee‐Chen Chang
- Cited by
- Cancer ResearchOncologyHepatology
- Journals
- Journal of Clinical Oncology (7 papers)Cancer (5 papers)Cancer Chemotherapy and Pharmacology (4 papers)
- Partner nations
- TaiwanUnited StatesNew Zealand
In The Last Decade
Wing‐Kai Chan
56 papers receiving 3.1k citations
Hit Papers
Peers
Comparison fields: 5 of 118
- Cancer Research 828
- Oncology 1.4k
- Hepatology 302
- Pulmonary and Respiratory Medicine 1.2k
- Otorhinolaryngology 138
Countries citing papers authored by Wing‐Kai Chan
This map shows the geographic impact of Wing‐Kai Chan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wing‐Kai Chan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wing‐Kai Chan more than expected).
Fields of papers citing papers by Wing‐Kai Chan
This network shows the impact of papers produced by Wing‐Kai Chan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wing‐Kai Chan. The network helps show where Wing‐Kai Chan may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Wing‐Kai Chan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 1 | |
| 2 | 2024 | 1 | |
| 3 | 2022 | 4 | |
| 4 | 2021 | 11 | |
| 5 | Pretreatment Epidermal Growth Factor Receptor ( EGFR ) T790M Mutation Predicts Shorter EGFR Tyrosine Kinase Inhibitor Response Duration in Patients With Non–Small-Cell Lung Cancerbreakdown → | 2012 | 429 |
| 6 | 2011 | 63 | |
| 7 | 2011 | 26 | |
| 8 | 2009 | 404 | |
| 9 | 2007 | 163 | |
| 10 | 2007 | 122 | |
| 11 | 2005 | 17 | |
| 12 | 2003 | 164 | |
| 13 | 2001 | 23 | |
| 14 | 1997 | 9 | |
| 15 | 1995 | 27 | |
| 16 | 1994 | 56 | |
| 17 | 1987 | 1 | |
| 18 | 1982 | 9 | |
| 19 | 1982 | 18 | |
| 20 | 1981 | 68 |
About Wing‐Kai Chan
Wing‐Kai Chan is a scholar working on Oncology, Hepatology, Pharmacology, Otorhinolaryngology and Pulmonary and Respiratory Medicine, having authored 57 papers that have together received 3.2k indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (14 papers), Hepatocellular Carcinoma Treatment and Prognosis (9 papers), Colorectal Cancer Treatments and Studies (8 papers), Lung Cancer Research Studies (7 papers), Pharmacogenetics and Drug Metabolism (6 papers), Cancer therapeutics and mechanisms (6 papers), Lung Cancer Treatments and Mutations (5 papers) and Neuroendocrine Tumor Research Advances (5 papers). The work is most often cited by research in Cancer Research (828 citations), Oncology (1.4k citations), Hepatology (302 citations), Pulmonary and Respiratory Medicine (1.2k citations) and Otorhinolaryngology (138 citations). Wing‐Kai Chan has collaborated with scholars based in Taiwan, United States and New Zealand. Frequent co-authors include Pan‐Chyr Yang, Ang Yuan, Sung‐Liang Yu, Yee Chao, Jeremy J.W. Chen, Jin‐Yuan Shih, Hsuan‐Yu Chen, Gee‐Chen Chang, Wei J. Chen and Chiou-Ling Cheng. Their work appears in journals such as Journal of Clinical Oncology, Cancer, Cancer Chemotherapy and Pharmacology, Drug Information Journal and Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.